Degrees:
PhD, MSc, Molecular Biology - Laval University
BSc, Biological Sciences - Universite Paris V
Development:
Emotional Intelligence
Situational Leadership
Change Management
Finance
OKRs, KPIs
Principles of Ownership, Control, Access, and Possession (OCAP®)
Languages:
Fluent in English, French, and Portuguese
Executive Operations:
Profit & Loss Accountability
Audit Oversight
Financial Operations
Human Resources, Belonging and Performance Culture Stewardship
Governance, Risk & Compliance
Data Stewardship
Program Strategy & Implementation
Legal & Contract Oversight
Go-to-Market Strategy Support
Strategic Communication & Marketing Enablement
Research & Development (R&D):
Program Design & Delivery
Partnership Development
Clinical Trial Oversight (Phases I–III)
Community Research
Good Clinical Practices (GCP) and Pharmacovigilance
Prototype Development, Efficacy and Safety Product Validation at Accredited Testing Laboratories (GMP/GLP-Compliant, BSL-2/3) under ASTM, ASHRAE, ISO, UL, and Nemko Standards
Scientific & Technical Due Diligence
Technology Sourcing & Evaluation
Health Product Software-as-a-Service (SaaS) & Dashboard Development
Peer-Reviewed Publications
Logic Models, Summative/Formative Program Evaluations
Market Experience:
Growth Stages: Pre-Seed, Series A–C, Post-IPO
Primary Markets: Canada, United States
Secondary Markets: United Kingdom, Germany, Australia
Investment Oversight:
$5-15 M Portfolios
Scientific Due-Diligence, Mergers & Acquisition Support
Strategic and Targeted Investments in Research, Technology, and Capacity Building
Domains and Partnerships:
Local, Provincial, Territorial, and Federal Government Agencies
Indigenous Governments and Organizations
Medium to Large Universities, Schools
Startups and Scaleups
Non-Profit, Charitable, and Community-Based, and Sports Promotion Organizations
Molecular Biology Across Diverse Fields, Including Genetics, Neuroscience, Microbiology, Public Health, and Emerging Areas (Photonics) at the Intersection With Physics and Engineering.
Regulatory:
Health Canada's Therapeutic Products Directorate (TPD), Natural and Non-prescription Health Products Directorate (NNHPD), Controlled Substances and CNS Branch, Veterinary Drugs Directorate (VDD), Pest Management Regulatory Agency and Associated Guidance Documents/Acts
U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) and Investigational Device Exemption (IDE) Regulations
Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)
Canada Revenue Agency's Charities Directorate
Treasury Board Budget Submissions
Chief Operating Officer - One Yukon Coalition
2023 - Present (Calgary)
Led organizational growth and One Health innovation across Northern Canada with full P&L responsibility, overseeing strategy, operations, governance, partnerships, and program delivery.
Built a high-performing team, secured charitable status, established national and international collaborations, and expanded evidence-generation programs spanning environmental monitoring, respiratory viruses, toxic drugs, and community-based diagnostic technologies.
Director, Clinical Science - R-Zero
2021 - 2023 (Salt Lake City, USA)
Led R-Zero’s scientific programming with Mayo Clinic, Harvard, and Columbia University partners, integrating light and sensor technologies to advance infection prevention in public settings.
Directed new product validation, launched the Salt Lake City R&D lab, and supported Series C funding and major enterprise sales.
Director, Clinical Research - CleanSlate
2020 - 2021 (Toronto)
Positioned CleanSlate's scientific division as a market leader in SARS-CoV-2 efficacy research, testing, and product validation.
Launched the company’s microbiology laboratory in Toronto and led a team of biologists and engineers through Health Canada registration, securing approval under the updated PCPA framework.
Director, Clinical Science - Aurora
2019 - 2020 (Edmonton)
Directed global clinical studies on novel treatments for epilepsy and pain, including a high-visibility partnership with the Ultimate Fighting Championship (UFC).
Team Lead, Project and Initiatives - Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction
2017 - 2018 (Calgary)
Allocated targeted Treasury Board investments to support public safety personnel, contributing to strategic planning, advisory board formation, program evaluation, and transparent public reporting.
Manager - Industry and Technology Initiatives - Alberta Innovates
2015 - 2017 (Edmonton)
Led province-wide research and capacity-building investments, overseeing peer review, fund allocation, and reporting.
Guided the team through an organizational merger while ensuring strategic alignment and program continuity.
Postdoctoral Fellow - University of Toronto, and University of Calgary
2011 - 2015 (Calgary)
Contributed to international research identifying a genetic link between cataracts and Alzheimer’s disease, advancing understanding of neurodegenerative conditions
Current Committees:
Community Member (Second Term), Health Canada Science Advisory Committee on Pest Control Products
Ad hoc Member, Canadian Public Health Laboratory Network (CPHLN) - Data Governance & Reporting, and Surveillance Strategy & Pathogen Prioritization Task Forces
Board Member, Mindelio/Heros Biotech™